Search Results

ABT-199 50mg 50mg  | Purity Not Available

Adooq Bioscience

ABT-199 is a so-called BH3-mimetic drug, which is designed to block the function of the protein Bcl 2.

More Information Supplier Page

ABT-199 25mg 25mg  | Purity Not Available

Adooq Bioscience

ABT-199 is a so-called BH3-mimetic drug, which is designed to block the function of the protein Bcl 2.

More Information Supplier Page

ABT-199 100mg 100mg  | Purity Not Available

Adooq Bioscience

ABT-199 is a so-called BH3-mimetic drug, which is designed to block the function of the protein Bcl 2.

More Information Supplier Page

VU 0361737 25mg 25mg  | Purity Not Available

Adooq Bioscience

VU 0361737 is a selective positive allosteric modulator at mGluR-4 (EC50 values are 240 and 110 nM at human and rat receptors respectively).

More Information Supplier Page

VU 0361737 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

VU 0361737 is a selective positive allosteric modulator at mGluR-4 (EC50 values are 240 and 110 nM at human and rat receptors respectively).

More Information Supplier Page

VU 0361737 10mg 10mg  | Purity Not Available

Adooq Bioscience

VU 0361737 is a selective positive allosteric modulator at mGluR-4 (EC50 values are 240 and 110 nM at human and rat receptors respectively).

More Information Supplier Page

AT13148 5mg 5mg  | Purity Not Available

Adooq Bioscience

AT13148 is a novel oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity, which shows a distinct mechanism of action from other AKT inhibitors.

More Information Supplier Page

AT13148 25mg 25mg  | Purity Not Available

Adooq Bioscience

AT13148 is a novel oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity, which shows a distinct mechanism of action from other AKT inhibitors.

More Information Supplier Page

AT13148 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

AT13148 is a novel oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity, which shows a distinct mechanism of action from other AKT inhibitors.

More Information Supplier Page